New hope for bile duct cancer: liver transplant after Chemo-Radiation

NCT ID NCT04378023

Recruiting now Disease control Sponsor: Hospital Vall d'Hebron Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new approach for people with a certain type of bile duct cancer that cannot be removed by surgery. Participants first receive chemotherapy and radiation, then a liver transplant. The goal is to see if this combination helps patients live longer and stay cancer-free. The trial is for patients aged 70 or younger with small tumors and no spread to lymph nodes or other organs.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UNRESECTABLE CHOLANGIOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cholangiocarcinoma hilar cholangiocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

UNRESECTABLE CHOLANGIOCARCINOMA

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Department of HPB Surgery and Transplants, Hospital Vall d´Hebron
RECRUITING

Barcelona, Barcelona, 08035, Spain

Contact Phone: •••-•••-•••• Email: •••••@•••••